FROM Jonathan Rockoff
Pfizer-Allergan Merge in Largest Inversion Deal Pfizer and Allergan are merging to create the world’s biggest drug company, worth $155 billion. The deal — which will move corporate headquarters to Ireland — is the biggest so-called "inversion" ever. An "inversion" is a way to avoid paying US taxes. Jonathan Rockoff, who covers the pharmaceutical industry for the Wall Street Journal , has the details.
Expiring Patents, Drug Prices and the Hazy Market for Generics Patents are about to expire on two of the world's best-selling prescription drugs. Prices for cholesterol-fighter Lipitor and the blood-thinner Plavix are likely to drop by 80 percent when they're replaced by generics. But that's not all. The drug industry will be faced with an unprecedented wave of expiring patents in the next few years. What will the expiration of patents on many other drugs mean for Big Pharma? How is the industry fighting back? Will consumers get the benefits they deserve?
'Do-or-die' time on healthcare bill President Trump has demanded a House vote today on replacing Obamacare…whatever the details might be. Despite his campaign promise that nobody would lose health insurance, that's possible for 24 million people if he were finally to sign this bill into law.
The airline electronics ban and what it means President Trump's Department of Homeland Security has banned all electronic devices larger than cell phones on some foreign airlines flying direct to the US. It's causing confusion as well as inconvenience. Is the motive really just increased security?
House Republicans release their Obamacare replacement As two House committees take up "repeal and replacement" of "Obamacare," there may be life left in the Affordable Care Act after all. Even Republicans are divided, and proposed changes won't make good on President Trump's promise to provide "health insurance for everybody."